SAPCD2 further promotes progression and metastasis in different human types of cancer by activating the Wnt/β-catenin, JAK/STAT, TGF-β, MAPK, and NF-κB signaling pathways, all of which have been reported to play crucial roles in cancer progression and metastasis (35–40). This evidence concerns the gene SOAT1 and cancer.